Intended for healthcare professionals


Update to living WHO guideline on drugs for covid-19

BMJ 2021; 372 doi: (Published 31 March 2021) Cite this as: BMJ 2021;372:n860

This living guideline by Lamontagne and colleagues (BMJ 2020;370:m3379) has been updated. For the latest update, visit doi:10.1136/bmj.m3379. The latest version of this WHO living guidance provides a recommendation against ivermectin in patients with covid-19 regardless of disease severity, except in the context of a clinical trial.